Viewing Study NCT00237250


Ignite Creation Date: 2025-12-24 @ 5:15 PM
Ignite Modification Date: 2026-02-04 @ 8:09 AM
Study NCT ID: NCT00237250
Status: COMPLETED
Last Update Posted: 2012-05-07
First Post: 2005-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prediabetic State View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pre-diabetes View
None vildagliptin View
None IGT View